Complexation of chromium (III) with the antifibrinolytic drug tranexamic acid: Formation, kinetics, and molecular modeling studies
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Molecular Liquids"
DOI: 10.1016/j.molliq.2021.115513
Abstract: Abstract Tranexamic acid (TXA) is widely used as an antifibrinolytic drug, inhibits fibrinolysis by blocking lysine-binding sites on plasminogen, limiting the activation of plasmin; and therefore, prevents excessive blood loss from trauma, surgery (e.g., cardiac,… read more here.
Keywords: antifibrinolytic drug; chromium iii; tranexamic acid; formation ... See more keywords